Rankings
▼
Calendar
▼
MIST Q3 2018 Earnings Report — Milestone Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
Milestone Pharmaceuticals Inc.
MIST
Q3 2018 Earnings
Reported September 29, 2018
Quarter Comparison
Revenue
Operating Income
EPS (Diluted)
Free Cash Flow
Metric
Q3 2018
Q2 2018
Q3 2017
QoQ Change
YoY Change
Revenue
$0
$0
—
—
—
Op. Income
-$6M
-$4M
—
-57.4%
—
EPS (Diluted)
$-0.24
$-0.15
—
-60.0%
—
Free Cash Flow
-$6M
-$3M
—
-63.4%
—
marketcaparena.com
Income Statement
Item
Amount
REVENUE
$0
Cost of Revenue
$0
GROSS PROFIT
$0
R&D Expenses
$4M
Selling & Marketing
$1M
General & Administrative
$646.0K
SG&A Expenses
$2M
Other Expenses
$0
Operating Expenses
$6M
Cost & Expenses
$6M
OPERATING INCOME
-$6M
Interest Income
$85.0K
Interest Expense
$0
Other Income/Expenses
$85.0K
INCOME BEFORE TAX
-$6M
Income Tax Expense
$0
Net Income from Continuing Ops
-$6M
Net Income from Discontinued Ops
$0
Other Adjustments
$0
NET INCOME
-$6M
Net Income Deductions
$0
BOTTOM LINE NET INCOME
-$6M
D&A
$3.0K
EBIT
-$6M
EBITDA
-$6M
EPS
-$0
EPS Diluted
-$0
marketcaparena.com
Cash Flow Statement
Item
Amount
Net Income
-$6M
Depreciation & Amortization
$3.0K
Stock-Based Compensation
$85.0K
Deferred Income Tax
$0
Other Non-Cash Items
$1M
Change in Working Capital
$21.0K
OPERATING CASH FLOW
-$6M
Capital Expenditure
$0
Acquisitions (Net)
$0
Purchases of Investments
-$9M
Sales/Maturities of Investments
$983.0K
Other Investing Activities
-$8M
NET CASH FROM INVESTING
-$8M
Net Debt Issuance
$0
Common Stock Repurchased
$0
Common Dividends Paid
$0
Other Financing Activities
$0
NET CASH FROM FINANCING
$0
FREE CASH FLOW
-$6M
Net Change in Cash
-$14M
marketcaparena.com
← FY 2018
MIST Overview
Q4 2018 →